Global Intrauterine Devices Market 2015-2019
About Intrauterine devices
Intrauterine devices (IUDs) are contraceptive medical implants used to prevent pregnancies for a long period of time. They are also known as long-acting reversible contraceptive devices. An IUD is a T-shaped device, made of flexible plastic, with a copper wire wrapped around its stem, and is considered a safe and reliable method of sterilization for women. It is inserted into the uterus, and its primary aim is to prevent the fertilization of the egg by causing changes, such as thickening or toxicity of the cervical mucus, thus preventing fertilization by a sperm. There are two types of IUDs, namely, copper IUD (containing copper) and hormone-releasing IUDs (containing the progesterone hormone). Mirena and ParaGard are some of the prominent brands available in the market.
Technavio's analysts forecast the global intrauterine devices market to grow at a CAGR of 3.44% over the period 2014-2019.
Covered in this report
In this report, Technavio covers the present scenario and growth prospects of the global intrauterine devices market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of following type of products: Hormonal IUDs and copper IUDs.
Technavio's report, Global intrauterine devices market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also presents the vendor landscape and a corresponding detailed analysis of the top three vendors in the market. Also, it discusses the major drivers and challenges in the market, as well as the key trends.
Technavio Announces the Publication of its Research Report – Global Intrauterine Devices Market 2015-2019
Technavio recognizes the following companies as the key players in the Global Intrauterine Devices Market: Actavis, Bayer and Teva Pharmaceutical
Other Prominent Vendors in the market are: SMB, Brecuro Medical, Eurogine, OCON Medical, Tespro, Pregna, Effik International, Medisafe Distribution, HLL Lifecare, HRA Pharma, Besins HealthCare, and Trimedic Supply Network.
Commenting on the report, an analyst from Technavio’s team said: “An increase in the number of unplanned pregnancies has increased the demand for contraceptives among several end users. At least 40% of pregnancies worldwide are unplanned, and this percentage is expected to rise. In 2012, approximately 85 million of 213 million pregnancies were unintended. Governments and NGOs are taking initiatives and implementing programs to curb unplanned pregnancies. The development of advanced contraceptives to improve safety, convenience, and benefits will also positively influence the market growth.”
According to the report, knowledge about family planning has increased the demand for contraceptives, especially IUDs, among several end users. IUDs are the world's most common form of reversible contraception and provide long-term birth control. More than 80% of IUD users, nearly 140 million women, are in Asia.
Further, the report states that lack of social acceptance remains the primary challenge for consumers to openly buy and use contraceptive devices due to morals and culture, as many people in conservative countries perceive contraception as immoral and against their religious sentiments.
Actavis, Bayer, Teva Pharmaceutical, SMB, Brecuro Medical, Eurogine, OCON Medical, Tespro, Pregna, Effik International, Medisafe Distribution, HLL Lifecare, HRA Pharma, Besins HealthCare,Trimedic Supply Network.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook